Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shisa family member 8 (SHISA8) is a membrane-associated protein predominantly expressed in the brain and adrenal gland, with lower levels in other tissues[4]. It is part of the AMPA receptor complex and is predicted to play a role in the regulation of short-term neuronal synaptic plasticity, possibly through the trafficking and modulation of AMPA-type glutamate receptors at synapses[1][2][3][4][5]. SHISA8 belongs to the Shisa protein family, is not classified as a receptor or classic druggable target, and is not currently implicated as a therapeutic target or clinically actionable biomarker. There is no reported direct involvement in major disease categories such as cancer, inflammation, or neurodegeneration, but its function in synaptic transmission suggests importance in neuronal signaling pathways[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Shisa family member 8 (SHISA8).